Outset Net Receivables vs Short Long Term Debt Analysis
OM Stock | USD 0.88 0.02 2.22% |
Outset Medical financial indicator trend analysis is much more than just breaking down Outset Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Outset Medical is a good investment. Please check the relationship between Outset Medical Net Receivables and its Short Long Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.
Net Receivables vs Short Long Term Debt
Net Receivables vs Short Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Outset Medical Net Receivables account and Short Long Term Debt. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Outset Medical's Net Receivables and Short Long Term Debt is -0.48. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Short Long Term Debt in the same time period over historical financial statements of Outset Medical, assuming nothing else is changed. The correlation between historical values of Outset Medical's Net Receivables and Short Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Outset Medical are associated (or correlated) with its Short Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt has no effect on the direction of Net Receivables i.e., Outset Medical's Net Receivables and Short Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.48 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Net Receivables
Short Long Term Debt
The total of a company's short-term and long-term borrowings.Most indicators from Outset Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Outset Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.As of the 26th of November 2024, Tax Provision is likely to grow to about 549.1 K, while Selling General Administrative is likely to drop about 30.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 6.2M | 6.3M | 5.8M | 4.9M | Interest Income | 498K | 3.3M | 10.2M | 10.7M |
Outset Medical fundamental ratios Correlations
Click cells to compare fundamentals
Outset Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Outset Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 88.4M | 403.8M | 463.5M | 400.1M | 313.8M | 333.8M | |
Short Long Term Debt Total | 29.1M | 38.6M | 37.8M | 103.2M | 136.2M | 68.5M | |
Other Current Liab | 11.6M | 26.8M | 41.3M | 40.0M | 34.6M | 29.4M | |
Total Current Liabilities | 24.9M | 36.7M | 51.7M | 51.9M | 55.3M | 42.3M | |
Total Stockholder Equity | (372.2M) | 328.6M | 374.1M | 246.0M | 122.9M | 75.4M | |
Other Liab | 351K | 810K | 1.0M | 264K | 303.6K | 572.2K | |
Net Tangible Assets | (372.2M) | 328.6M | 374.1M | 246.0M | 282.9M | 297.0M | |
Property Plant And Equipment Net | 7.9M | 23.3M | 20.2M | 22.0M | 18.6M | 17.4M | |
Current Deferred Revenue | 883K | 3.2M | 6.3M | 8.7M | 11.7M | 12.3M | |
Net Debt | (7.9M) | (256.4M) | (144.5M) | 30.0M | 67.7M | 71.1M | |
Retained Earnings | (372.6M) | (494.1M) | (626.0M) | (789.0M) | (961.7M) | (913.7M) | |
Accounts Payable | 5.0M | 4.9M | 1.8M | 603K | 5.8M | 6.1M | |
Cash | 36.9M | 295.0M | 182.3M | 73.2M | 68.5M | 126.4M | |
Non Current Assets Total | 8.7M | 57.9M | 53.7M | 26.5M | 22.6M | 31.7M | |
Non Currrent Assets Other | 82K | 1.4M | 156K | 1.2M | 3.9M | 4.1M | |
Other Assets | 825K | 34.7M | 33.5M | 4.5M | 5.1M | 4.9M | |
Long Term Debt | 21.6M | 29.7M | 29.8M | 96.3M | 130.1M | 136.6M | |
Cash And Short Term Investments | 70.1M | 314.9M | 339.5M | 287.5M | 203.3M | 249.0M | |
Net Receivables | 3.9M | 6.5M | 25.6M | 28.1M | 33.0M | 18.0M | |
Common Stock Shares Outstanding | 42.3M | 42.7M | 45.6M | 48.2M | 49.6M | 47.4M | |
Short Term Investments | 33.2M | 19.9M | 157.1M | 214.3M | 134.8M | 122.6M | |
Liabilities And Stockholders Equity | 88.4M | 403.8M | 463.5M | 400.1M | 313.8M | 333.8M | |
Non Current Liabilities Total | 435.6M | 38.5M | 37.7M | 102.2M | 135.6M | 157.1M | |
Capital Lease Obligations | 0.0 | 8.9M | 8.0M | 6.9M | 6.1M | 5.6M | |
Inventory | 4.6M | 18.4M | 39.2M | 51.5M | 49.2M | 30.4M | |
Other Current Assets | 1.1M | 12.4M | 11.1M | 6.6M | 5.7M | 6.9M | |
Other Stockholder Equity | (409.1M) | 822.6M | 1.0B | 1.0B | 1.1B | 648.2M | |
Total Liab | 460.6M | 75.2M | 89.4M | 154.1M | 190.9M | 187.9M | |
Net Invested Capital | (343.1M) | 358.3M | 403.8M | 342.3M | 253.0M | 138.4M | |
Property Plant And Equipment Gross | 7.9M | 23.3M | 20.2M | 22.0M | 35.0M | 20.4M | |
Total Current Assets | 79.6M | 345.9M | 409.8M | 373.6M | 291.2M | 302.1M | |
Accumulated Other Comprehensive Income | 22K | 1K | (184K) | (564K) | 68K | 71.4K | |
Net Working Capital | 54.7M | 309.2M | 358.1M | 321.7M | 235.9M | 259.8M | |
Short Term Debt | 7.5M | 1.8M | 2.3M | 2.6M | 3.2M | 2.4M | |
Property Plant Equipment | 7.9M | 23.3M | 20.2M | 15.9M | 18.3M | 15.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.74) | Revenue Per Share 2.235 | Quarterly Revenue Growth (0.06) | Return On Assets (0.27) | Return On Equity (1.41) |
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.